OpGen Investor Relations Material

OpGen, Inc. is a precision medicine company that focuses on developing molecular diagnostic tools for the detection of infectious diseases. The company's products and services include rapid diagnostic tests and bioinformatics solutions designed to identify bacterial pathogens and antibiotic resistance. OpGen serves healthcare providers and laboratories, aiming to improve patient outcomes through faster, more accurate diagnostics for conditions such as urinary tract infections and bloodstream infections. The company is headquartered in Rockville, United States, and its shares are listed on the NASDAQ.